MaxCyte, Inc. Common Stock
MXCT Real Time Price USDRecent trades of MXCT by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by MXCT's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Docking station Mar. 12, 2024
-
Patent Title: Docking station Mar. 05, 2024
-
Patent Title: Tray Sep. 12, 2023
-
Patent Title: Electroporation gasket Sep. 05, 2023
-
Patent Title: Methods for modifying genomic dna Mar. 21, 2023
-
Patent Title: Processing assembly Jan. 24, 2023
-
Patent Title: Electroporation device screen with pattern Oct. 18, 2022
-
Patent Title: Electroporation device Oct. 04, 2022
-
Patent Title: Engineering and delivery of therapeutic compositions of freshly isolated cells May. 17, 2022
-
Patent Title: Electroporation processing assembly Feb. 22, 2022
-
Patent Title: Electroporation processing assembly Feb. 15, 2022
-
Patent Title: Electroporation device Jan. 25, 2022
-
Patent Title: Electroporation device Jan. 25, 2022
-
Patent Title: Electroporation device Jan. 25, 2022
-
Patent Title: Electroporation device Jan. 25, 2022
-
Patent Title: Electroporation gasket Sep. 28, 2021
-
Patent Title: Electroporation device Jun. 22, 2021
-
Patent Title: Electroporation device Jun. 22, 2021
-
Patent Title: Engineering and delivery of therapeutic compositions of freshly isolated cells May. 26, 2020
-
Patent Title: Methods and compositions for generating stable transfected cells Jun. 11, 2019
-
Patent Title: Engineering and delivery of therapeutic compositions of freshly isolated cells Jun. 06, 2017
-
Patent Title: Methods and devices related to a regulated flow electroporation chamber Jan. 17, 2017
-
Patent Title: Engineering and delivery of therapeutic compositions of freshly isolated cells Sep. 15, 2015
-
Patent Title: Engineering and delivery of therapeutic compositions of freshly isolated cells May. 28, 2013
-
Patent Title: Computerized electroporation Aug. 02, 2011
-
Patent Title: Methods and devices related to a regulated flow electroporation chamber Aug. 10, 2010
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of MXCT in WallStreetBets Daily Discussion
Recent insights relating to MXCT
Recent picks made for MXCT stock on CNBC
ETFs with the largest estimated holdings in MXCT
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view MXCT Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.